Skip to content

Dear Doctor, Aspen Pharmacare Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), is conducting a retail level recall of Zantac (ranitidine) tablets, effervescent tablets, syrup and ampoules. The TGA has not requested that a Dear Doctor letter be sent for this retail level product recall. We are informing you as the potentially…

Read More

As of 1 September 2015 Aspen has divested to Strides (Australia) Pharma Pty Ltd a portfolio of its products commercialised in Australia and New Zealand. The range primarily includes the Aspen Generics Product Portfolio and business, including the Chemists’ Own range. Strides, to be called Arrow Pharmaceuticals in Australia, has a core focus on generic product development, and with its strong manufacturing and procurement capabilities has better opportunities to promote and grow this portfolio.

Read More

Aspen Nutritionals Australia Pty Ltd is very concerned that a customer has reported finding a lizard in a tin of S-26 Original Progress formula, and is voluntarily withdrawing the affected batch number 40727482A2 while it investigates the issue.  No other products or batches are affected, and consumers can continue to use these with confidence.

Read More

Port Elizabeth – The Nelson Mandela Metropolitan University (NMMU) today conferred the degree of Doctor of Commerce (honoris causa) on Stephen Saad, Aspen Group Co-Founder and Chief Executive. Chancellor of the NMMU, Santie Botha said, ‘’It is an honour for NMMU to confer this honorary degree on Stephen Saad. His vision and drive in the world of business is inspiring and as NMMU we acknowledge the turn-around he orchestrated in a Port Elizabeth-based company that provides jobs to people in an economically struggling province’’.

Read More

DUBLIN, Feb. 28, 2014 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO;TASE) announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash. The products are primarily sold through the mass retail channel and include the Herron® range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.

Read More

Aspen Pharmacare Australia Pty Ltd wish to advise that Di-Gesic (dextropropoxyphene HCl 32.5mg/paracetamol 325mg)) stock has been released to wholesalers today.

Read More

The Australian Packaging Covenant is a voluntary initiative by Government and Industry to reduce the environmental effects of packaging. It is designed to minimise the environmental impacts arising from the disposal of used packaging, conserve resources through better design and production processes and facilitate the re-use and recycling of used packaging materials. Here you can view Aspen Australia's plan and report.

Read More
Scroll To Top